Loading…
Teladoc Health, Inc. is projected to rise to $8.44 by 2027, a +28% move from its current price of $6.59. TDOC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.45 | $6.60 | $6.75 | +0.08% |
| May 30 | $6.39 | $6.60 | $6.82 | +0.16% |
| May 31 | $6.35 | $6.61 | $6.87 | +0.23% |
| Jun 1 | $6.32 | $6.61 | $6.92 | +0.31% |
| Jun 2 | $6.29 | $6.62 | $6.96 | +0.39% |
| Jun 3 | $6.26 | $6.62 | $7.00 | +0.47% |
| Jun 4 | $6.24 | $6.63 | $7.04 | +0.55% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.24 | $6.63 | $7.04 | +0.55% |
| Week 2 | $6.12 | $6.66 | $7.26 | +1.10% |
| Week 3 | $6.03 | $6.70 | $7.44 | +1.65% |
| Week 4 | $5.97 | $6.74 | $7.60 | +2.20% |
| Week 5 | $5.92 | $6.77 | $7.75 | +2.76% |
| Week 6 | $5.87 | $6.81 | $7.89 | +3.32% |
| Week 7 | $5.84 | $6.85 | $8.03 | +3.89% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Teladoc Health, Inc. provides virtual healthcare services worldwide through its Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services across general medical, expert medical, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems.
The BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc and BetterHelp brands. Teladoc Health, Inc.
was incorporated in 2002 and is headquartered in New York, New York. It was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018.
Teladoc Health, Inc. (TDOC) trades at $6.57 with a market cap of $1.19B. It ranks 2399 among all assets.
The current price sits in a defined technical frame and the near-term outlook is neutral, with a forecast that suggests a flat start in 2026 before a longer-term upside emerges.
From 2027 onward, the forecast shows bullish momentum. The 2027 avg is $8.42 and the 2028 avg is $8.64, with 2029 avg $9.18 and 2030 avg $9.63. The forecast extends to 2031 $9.53, 2032 $11.07, 2033 $13.09, 2034 $14.01, and 2035 $14.76.
Looking further out, 2040 is $21.05 on avg and 2050 is $36.19 on avg, with respective maxs of $34.35 and $64.15. The associated ROI figures rise through the horizon, reaching 46.6 in 2030, 220.3 in 2040, and 450.8 in 2050, all while sentiment remains bullish in these years.
A major floor 32.2% below — a decisive break under it would weaken the trend.
The nearest floor, 15.9% below — buyers have tended to step in here.
The nearest ceiling, 10.0% above — a clean break opens room to run.
A major ceiling 24.0% above — clearing it would confirm fresh momentum.
Key TDOC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TDOC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.56 | Buy | $6.57 | Buy |
| MA 10 | $6.55 | Buy | $6.57 | Buy |
| MA 20 | $6.60 | Sell | $6.47 | Buy |
| MA 50 | $5.94 | Buy | $6.15 | Buy |
| MA 100 | $5.80 | Buy | $6.17 | Buy |
| MA 200 | $6.79 | Sell | $6.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.73 | Neutral |
| Stoch RSI (14) | 16.66 | Buy |
| CCI (20) | -2.99 | Neutral |
| Williams %R (14) | -73.33 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -9.10 | Sell |
| Bollinger %B (20,2) | 0.49 | Neutral |
| Stochastic %K (14) | 26.67 | Neutral |
| TRIX (15) | 0.59 | Buy |
| Awesome (5,34) | 0.35 | Buy |
| Ultimate (7,14,28) | 62.66 | Neutral |
| Momentum (10) | -0.18 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 6.61 | Sell |
| ADX (14) | 20.08 | Buy |
| ATR (14) | 0.12 | Info |
The near-term technical picture is neutral, with RSI(14) at 60. The price is above the 50-day moving average (SMA50) of $5.90 and below the 200-day moving average (SMA200) of $6.80.
Support is identified at $5.22 and resistance at $7.25, framing a 30-day range shown as $5.60 to $7.71. These levels help define potential near-term moves for TDOC.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.47 | $6.59 | $9.02 | 0% | Neutral | |
| $6.80 | $8.44 | $11.02 | +28% | Bullish | |
| $6.93 | $8.80 | $11.85 | +34% | Bullish | |
| $7.28 | $9.41 | $12.98 | +43% | Bullish | |
| $7.56 | $9.93 | $13.99 | +51% | Bullish | |
| $7.52 | $10.03 | $14.39 | +52% | Bullish | |
| $8.59 | $11.61 | $16.93 | +76% | Bullish | |
| $10.01 | $13.71 | $20.29 | +108% | Bullish | |
| $10.70 | $14.84 | $22.26 | +125% | Bullish | |
| $11.08 | $15.55 | $23.63 | +136% | Bullish | |
| $15.34 | $22.70 | $36.41 | +244% | Bullish | |
| $24.35 | $39.41 | $68.41 | +498% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.47 | $6.59 | $7.75 | +0.00% |
| June 2026 | $5.90 | $6.90 | $8.25 | +4.70% |
| July 2026 | $6.00 | $7.07 | $8.55 | +2.54% |
| August 2026 | $5.96 | $7.06 | $8.61 | -0.16% |
| September 2026 | $6.06 | $7.21 | $8.86 | +2.09% |
| October 2026 | $6.20 | $7.42 | $9.17 | +2.83% |
| November 2026 | $6.12 | $7.34 | $9.12 | -1.04% |
| December 2026 | $6.00 | $7.22 | $9.02 | -1.60% |
Click any year to see its month-by-month TDOC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Teladoc Health, Inc.'s 2026 outlook centres on $6.59, within a $4.47 to $9.02 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, TDOC could reach as high as $11.02, with a base case around $8.44 and support toward $6.80 — roughly +28% from $6.59. Momentum favours further upside here.
Expect TDOC to range from $6.93 to $11.85 through 2028. The $8.80 average target implies a +34% move from current prices. That is up +4% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The TDOC price prediction for 2029 points to an average of $9.41 (low $7.28, high $12.98) — a potential gain of +43% on today's $6.59. Momentum favours further upside here.
In 2030, TDOC is projected to trade between $7.56 and $13.99, averaging $9.93 — a potential gain of +51% from today's $6.59. That is up +6% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Teladoc Health, Inc.'s 2031 outlook centres on $10.03, within a $7.52 to $14.39 range. That is up +1% on the projected 2030 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2032, TDOC could reach as high as $16.93, with a base case around $11.61 and support toward $8.59 — roughly +76% from $6.59. Buyers look set to stay in control over this stretch.
Expect TDOC to range from $10.01 to $20.29 through 2033. The $13.71 average target implies a +108% move from current prices. That is up +18% on the projected 2032 average. Momentum favours further upside here.
The TDOC price prediction for 2034 points to an average of $14.84 (low $10.70, high $22.26) — a potential gain of +125% on today's $6.59. Buyers look set to stay in control over this stretch.
In 2035, TDOC is projected to trade between $11.08 and $23.63, averaging $15.55 — a potential gain of +136% from today's $6.59. That is up +5% on the projected 2034 average. Momentum favours further upside here.
Teladoc Health, Inc.'s 2040 outlook centres on $22.70, within a $15.34 to $36.41 range. That is up +46% on the projected 2035 average. That marks a +244% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, TDOC could reach as high as $68.41, with a base case around $39.41 and support toward $24.35 — roughly +498% from $6.59. Momentum favours further upside here.
Investing $1,000 in TDOC today (≈ 151.745068 TDOC) could be worth
$5,979.79
+$4,979.79 (+498%) by 2050 · US Dollar
Based on the average projected TDOC price of $39.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TDOCwould be worth at today's price.
$1,000 invested in TDOC on May 27, 2025 (≈ 141.242939 TDOC) would be worth
$930.79
-$69.21 (-6.9%) today · 0.93× · US Dollar
Based on a TDOC entry price of $7.08 vs. today's $6.59.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.48 | $1,016.98 | +1.7% |
| 1 month ago | $5.85 | $1,126.5 | +12.6% |
| 3 months ago | $5.35 | $1,231.78 | +23.2% |
| 6 months ago | $7.59 | $868.25 | -13.2% |
| 1 year ago | $7.08 | $930.79 | -6.9% |
| All time (5.0y) ago | $152.36 | $43.25 | -95.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TDOC forecast.
Our base-case forecast reaches $13.00 around 2033.
Implied market cap at $13.00: $2.35B
The multi-year forecast portrays a bullish trajectory from 2027 onward. The 2027 average price of $8.42 begins a pattern of rising averages through 2030 ($9.63) and beyond, with consistent bullish sentiment in the years that follow.
Key milestones include 2030 with an avg of $9.63 and a max of $13.73, yielding a 46.6 ROI. The 2040 forecast shows an avg of $21.05 with a max of $34.35 and a 220.3 ROI. By 2050, the avg is $36.19 with a max of $64.15 and a 450.8 ROI, with sentiment remaining BULLISH.
These figures depict a long-run upside potential, but they are estimates and not guarantees. Investors should weigh the implied upside against risks and the inherent uncertainty of future market moves.
Tap a question to reveal the answer.
2030: min $7.26, avg $9.63, max $13.73; ROI 46.6; sentiment BULLISH.
The forecast shows neutral in 2026 (avg $6.57, min $4.47, max $9.03; ROI 0) and bullish thereafter, with ROIs of 28.2 in 2027, 31.5 in 2028, 39.8 in 2029, 46.6 in 2030, 45.1 in 2031, 68.5 in 2032, 99.2 in 2033, 113.2 in 2034, 124.6 in 2035, 220.3 in 2040, and 450.8 in 2050.
Yes. The 2050 max is $64.15 with ROI 450.8 and sentiment BULLISH.
$1.19B.
Teladoc Health, Inc. Community Discussion
0Share your Teladoc Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.